BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Jun 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2010-05-22

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-22	Common Stock	M	7500	—	Acquired	94067	Direct
2010-06-07	Common Stock	M	5000	—	Acquired	99067	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-05-22	Restricted Stock Units	$0	M	7500	Disposed		Common Stock (7500)	Direct
2010-06-07	Restricted Stock Units	$0	M	5000	Disposed		Common Stock (5000)	Direct

Footnotes

F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.

F2: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.

F3: Original grant of restricted stock units vest 1/4th each on June 22, 2009, May 22, 2010, May 22, 2011 and May 22, 2012.

F4: Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.